Abstract 2035: Listen to the patients: Assessing the prognostic value of pre-treatment health-related quality of life in 1L DLBCL patients
Huang H, Datye A, Fan M, Knapp A, Balakrishnan R, Balasubramanian S, Chae J, Roth E, Nielsen T, Paulson J, Trask P. Abstract 2035: Listen to the patients: Assessing the prognostic value of pre-treatment health-related quality of life in 1L DLBCL patients. Cancer Research 2020, 80: 2035-2035. DOI: 10.1158/1538-7445.am2020-2035.Peer-Reviewed Original ResearchDiffuse large B-cell lymphoma patientsDiffuse large B-cell lymphomaInternational Prognostic IndexProgression free survivalPre-treatment HRQOLPrognostic valueOverall survivalHealth-related quality of lifePatient-reported health-related quality-of-lifeAssociated with better survival outcomesLarge B-cell lymphomaHigh risk of progressionQuality of lifeAnn Arbor stageB-cell lymphomaBetter survival outcomesKaplan-Meier methodAmerican Association for Cancer ResearchContribution to prognosisImprove risk stratificationCox proportional hazards modelsNovel treatment strategiesHRQOL subscale scoresStatus of patientsInformed treatment decisions